
Utah’s Division of Consumer Protection is pursuing a public‑nuisance and consumer‑sales‑practice lawsuit against pharmacy‑benefit managers Express Scripts and Optum, alleging they oversupplied opioids in the state. The case, filed in Utah’s Third Judicial District in December 2024, was sent back to state court after a federal judge’s removal order.
Express Scripts and Optum asked a three‑judge panel of the 10th Circuit Court of Appeals to move the case to federal court, arguing that the defendants’ work for federal employee and veteran programs brings the dispute under the federal officer removal statute. The defendants said the district judge’s reliance on a disclaimer in the complaint – which excluded the companies’ federal‑officer work – was inconsistent with rulings from the Second, Sixth and Eighth Circuits.
The core issue is whether the lawsuit, which claims the managers’ formularies and benefit plans led to a dramatic oversupply of opioids, should be decided under state law or federal law. If a federal court takes the case, the defendants could argue for an automatic stay of the state suit and potentially limit the remedies available to Utah.
Utah alleges the managers profited while opioid prescriptions in the nation quadrupled and Utah overdose deaths tripled. The state says the managers used their position to exacerbate the crisis. The defendants counter that the opioid flow cannot be separated between federal and non‑federal plans because the drugs pass through secondary markets where they are commingled.
For Utah consumers, the decision to keep the case in state court means the lawsuit will proceed under Utah law, which may allow broader consumer‑protection claims. No specific deadlines or steps for individuals are mentioned in the filing, but the outcome could affect how pharmacy‑benefit managers operate in the state and potentially lead to changes in prescription‑drug pricing or oversight.
Anyone who believes they have been harmed by oversupplied opioids or who receives notices related to this litigation should consider consulting an attorney to understand their rights and any possible participation in the case.
Keeping the case in Utah could let the state pursue wider public‑nuisance and consumer‑protection remedies than a federal court might allow.
If the lawsuit proceeds, Express Scripts and Optum could be pressured to change how they manage opioid formularies and benefit plans.
A ruling against the managers might lead to tighter controls on opioid distribution and possibly lower costs for patients.
Lawmakers in other states could use Utah’s lawsuit as a model to address opioid oversupply by pharmacy benefit managers.
Utah residents who receive communications about the case should consult a lawyer to assess any personal claims or obligations.
This article is general information based on Courthouse News Service and court or agency records available at publication time. It is not legal advice; laws and deadlines differ by state and by case. Published November 18, 2026.
Source: Courthouse News Service
No attorneys in Utah are listed in our directory yet. Lawyers are licensed state by state, so before hiring, check that the attorney is admitted to practice in Utah.